annual operating profit:
$14.54B+$4.78B(+48.88%)Summary
- As of today (April 16, 2025), NVS annual operating income is $14.54 billion, with the most recent change of +$4.78 billion (+48.88%) on December 31, 2024.
- During the last 3 years, NVS annual operating profit has risen by +$4.49 billion (+44.63%).
- NVS annual operating profit is now at all-time high.
Performance
NVS Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$3.53B-$97.00M(-2.67%)Summary
- As of today (April 16, 2025), NVS quarterly operating income is $3.53 billion, with the most recent change of -$97.00 million (-2.67%) on December 31, 2024.
- Over the past year, NVS quarterly operating profit has dropped by -$484.00 million (-12.06%).
- NVS quarterly operating profit is now -38.04% below its all-time high of $5.70 billion, reached on March 31, 2000.
Performance
NVS quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$14.54B+$948.00M(+6.97%)Summary
- As of today (April 16, 2025), NVS TTM operating income is $14.54 billion, with the most recent change of +$948.00 million (+6.97%) on December 31, 2024.
- Over the past year, NVS TTM operating profit has increased by +$2.81 billion (+23.98%).
- NVS TTM operating profit is now at all-time high.
Performance
NVS TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
NVS Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.9% | -12.1% | +24.0% |
| 3 y3 years | +44.6% | +93.3% | +85.6% |
| 5 y5 years | +60.1% | +50.1% | +56.8% |
NVS Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.0% | -12.1% | +101.1% | at high | +85.6% |
| 5 y | 5-year | at high | +83.0% | -12.1% | +280.0% | at high | +85.6% |
| alltime | all time | at high | +236.3% | -38.0% | +132.1% | at high | +724.2% |
Novartis AG Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $14.54B(+48.9%) | $3.53B(-2.7%) | $14.54B(+7.0%) |
| Sep 2024 | - | $3.63B(-9.6%) | $13.60B(+15.9%) |
| Jun 2024 | - | $4.01B(+19.0%) | $11.73B(+11.5%) |
| Mar 2024 | - | $3.37B(+30.6%) | $10.52B(+7.7%) |
| Dec 2023 | $9.77B(+22.9%) | $2.58B(+46.5%) | $9.77B(+9.2%) |
| Sep 2023 | - | $1.76B(-37.2%) | $8.94B(-0.7%) |
| Jun 2023 | - | $2.81B(+7.2%) | $9.01B(+6.9%) |
| Mar 2023 | - | $2.62B(+49.2%) | $8.43B(-2.7%) |
| Dec 2022 | $7.95B(-21.0%) | $1.75B(-3.9%) | $8.66B(+10.5%) |
| Sep 2022 | - | $1.83B(-18.0%) | $7.83B(-15.2%) |
| Jun 2022 | - | $2.23B(-21.9%) | $9.24B(-11.9%) |
| Mar 2022 | - | $2.85B(+207.0%) | $10.49B(+4.3%) |
| Dec 2021 | $10.06B(-0.9%) | $929.00M(-71.3%) | $10.06B(-14.6%) |
| Sep 2021 | - | $3.23B(-7.1%) | $11.77B(+7.5%) |
| Jun 2021 | - | $3.48B(+44.1%) | $10.95B(+11.5%) |
| Mar 2021 | - | $2.42B(-8.7%) | $9.82B(-3.2%) |
| Dec 2020 | $10.15B(+11.7%) | $2.64B(+9.6%) | $10.15B(+8.8%) |
| Sep 2020 | - | $2.41B(+2.6%) | $9.33B(+0.6%) |
| Jun 2020 | - | $2.35B(-14.3%) | $9.28B(-3.2%) |
| Mar 2020 | - | $2.74B(+50.5%) | $9.59B(+5.5%) |
| Dec 2019 | $9.09B(+8.1%) | $1.82B(-22.7%) | $9.09B(+5.3%) |
| Sep 2019 | - | $2.36B(-11.5%) | $8.63B(+1.4%) |
| Jun 2019 | - | $2.66B(+18.8%) | $8.51B(+2.8%) |
| Mar 2019 | - | $2.24B(+64.6%) | $8.27B(-1.5%) |
| Dec 2018 | $8.40B(-3.4%) | $1.36B(-39.2%) | $8.40B(-8.5%) |
| Sep 2018 | - | $2.24B(-7.9%) | $9.18B(-1.3%) |
| Jun 2018 | - | $2.43B(+2.5%) | $9.30B(+1.7%) |
| Mar 2018 | - | $2.37B(+10.6%) | $9.15B(+5.2%) |
| Dec 2017 | $8.70B(+5.2%) | $2.14B(-9.1%) | $8.70B(+8.6%) |
| Sep 2017 | - | $2.36B(+3.4%) | $8.01B(+1.1%) |
| Jun 2017 | - | $2.28B(+18.6%) | $7.93B(+2.4%) |
| Mar 2017 | - | $1.92B(+32.1%) | $7.74B(-6.4%) |
| Dec 2016 | $8.27B(-7.9%) | $1.46B(-35.9%) | $8.27B(-2.6%) |
| Sep 2016 | - | $2.27B(+8.4%) | $8.49B(+0.4%) |
| Jun 2016 | - | $2.09B(-14.6%) | $8.46B(-2.2%) |
| Mar 2016 | - | $2.45B(+46.2%) | $8.64B(-3.7%) |
| Dec 2015 | $8.98B(-19.0%) | $1.68B(-24.9%) | $8.98B(-7.0%) |
| Sep 2015 | - | $2.23B(-2.1%) | $9.65B(-5.0%) |
| Jun 2015 | - | $2.28B(-18.1%) | $10.16B(-8.2%) |
| Mar 2015 | - | $2.79B(+18.5%) | $11.06B(-0.3%) |
| Dec 2014 | $11.09B(+1.0%) | $2.35B(-14.2%) | $11.09B(+0.2%) |
| Sep 2014 | - | $2.74B(-14.0%) | $11.07B(+1.7%) |
| Jun 2014 | - | $3.18B(+13.1%) | $10.89B(+1.4%) |
| Mar 2014 | - | $2.81B(+20.7%) | $10.74B(-0.7%) |
| Dec 2013 | $10.98B(-4.6%) | $2.33B(-8.8%) | $10.82B(-3.4%) |
| Sep 2013 | - | $2.56B(-15.7%) | $11.20B(-3.4%) |
| Jun 2013 | - | $3.03B(+4.7%) | $11.59B(-0.6%) |
| Mar 2013 | - | $2.90B(+6.7%) | $11.67B(+1.4%) |
| Dec 2012 | $11.51B | $2.71B(-7.9%) | $11.51B(+16.3%) |
| Sep 2012 | - | $2.95B(-5.1%) | $9.89B(-0.0%) |
| Jun 2012 | - | $3.11B(+13.6%) | $9.89B(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $2.74B(+149.0%) | $10.11B(-6.2%) |
| Dec 2011 | $10.78B(-6.5%) | $1.10B(-62.8%) | $10.78B(-11.3%) |
| Sep 2011 | - | $2.95B(-11.2%) | $12.15B(+3.1%) |
| Jun 2011 | - | $3.32B(-2.5%) | $11.78B(+3.2%) |
| Mar 2011 | - | $3.41B(+38.1%) | $11.42B(-0.9%) |
| Dec 2010 | $11.53B(+15.5%) | $2.47B(-4.6%) | $11.53B(-1.5%) |
| Sep 2010 | - | $2.59B(-12.6%) | $11.70B(-0.4%) |
| Jun 2010 | - | $2.96B(-15.7%) | $11.74B(+5.4%) |
| Mar 2010 | - | $3.51B(+33.1%) | $11.15B(+14.2%) |
| Dec 2009 | $9.98B(+11.4%) | $2.64B(+0.1%) | $9.76B(+10.9%) |
| Sep 2009 | - | $2.63B(+11.4%) | $8.80B(+3.5%) |
| Jun 2009 | - | $2.36B(+11.3%) | $8.50B(-1.1%) |
| Mar 2009 | - | $2.12B(+26.4%) | $8.60B(-4.1%) |
| Dec 2008 | $8.96B(+32.2%) | $1.68B(-28.1%) | $8.96B(+18.1%) |
| Sep 2008 | - | $2.33B(-5.1%) | $7.59B(+4.0%) |
| Jun 2008 | - | $2.46B(-1.1%) | $7.30B(+6.0%) |
| Mar 2008 | - | $2.49B(+710.4%) | $6.88B(+2.3%) |
| Dec 2007 | $6.78B(-11.3%) | $307.00M(-85.0%) | $6.73B(-17.4%) |
| Sep 2007 | - | $2.04B(-0.1%) | $8.15B(+0.8%) |
| Jun 2007 | - | $2.04B(-12.4%) | $8.08B(-0.2%) |
| Mar 2007 | - | $2.33B(+35.4%) | $8.10B(+3.5%) |
| Dec 2006 | $7.64B(+17.4%) | $1.73B(-12.8%) | $7.83B(+8.8%) |
| Sep 2006 | - | $1.98B(-4.2%) | $7.19B(+1.3%) |
| Jun 2006 | - | $2.06B(+0.3%) | $7.10B(+3.1%) |
| Mar 2006 | - | $2.06B(+88.8%) | $6.88B(+5.8%) |
| Dec 2005 | $6.51B(+6.4%) | $1.09B(-42.3%) | $6.51B(-0.3%) |
| Sep 2005 | - | $1.89B(+2.1%) | $6.53B(+2.7%) |
| Jun 2005 | - | $1.85B(+10.1%) | $6.36B(+0.9%) |
| Mar 2005 | - | $1.68B(+51.1%) | $6.30B(+3.0%) |
| Dec 2004 | $6.12B(+8.6%) | $1.11B(-35.2%) | $6.12B(-3.8%) |
| Sep 2004 | - | $1.72B(-4.3%) | $6.36B(+4.1%) |
| Jun 2004 | - | $1.79B(+20.1%) | $6.11B(+5.7%) |
| Mar 2004 | - | $1.49B(+10.5%) | $5.78B(+2.5%) |
| Dec 2003 | $5.63B(+10.7%) | $1.35B(-8.0%) | $5.63B(+0.1%) |
| Sep 2003 | - | $1.47B(+0.4%) | $5.63B(+4.2%) |
| Jun 2003 | - | $1.46B(+8.3%) | $5.40B(+0.4%) |
| Mar 2003 | - | $1.35B(+0.4%) | $5.38B(-39.5%) |
| Dec 2002 | $5.09B(+17.7%) | $1.35B(+8.4%) | $8.89B(-481.5%) |
| Sep 2002 | - | $1.24B(-13.9%) | -$2.33B(-216.3%) |
| Jun 2002 | - | $1.44B(-70.3%) | $2.00B(+30.7%) |
| Mar 2002 | - | $4.86B(-149.2%) | $1.53B(+37.5%) |
| Dec 2001 | $4.33B(-11.4%) | -$9.87B(-277.0%) | $1.11B(>+9900.0%) |
| Sep 2001 | - | $5.58B(+474.3%) | $0.00(-100.0%) |
| Jun 2001 | - | $971.00M(-78.1%) | -$695.00M(+4.4%) |
| Mar 2001 | - | $4.44B(-140.4%) | -$666.00M(-212.7%) |
| Dec 2000 | $4.88B(+5.9%) | -$10.99B(-325.1%) | $591.00M(-94.9%) |
| Sep 2000 | - | $4.88B(+388.1%) | $11.58B(+72.9%) |
| Jun 2000 | - | $1.00B(-82.4%) | $6.70B(+17.6%) |
| Mar 2000 | - | $5.70B | $5.70B |
| Dec 1999 | $4.61B(-8.3%) | - | - |
| Dec 1998 | $5.03B | - | - |
FAQ
- What is Novartis AG annual operating income?
- What is the all time high annual operating profit for Novartis AG?
- What is Novartis AG annual operating profit year-on-year change?
- What is Novartis AG quarterly operating income?
- What is the all time high quarterly operating profit for Novartis AG?
- What is Novartis AG quarterly operating profit year-on-year change?
- What is Novartis AG TTM operating income?
- What is the all time high TTM operating profit for Novartis AG?
- What is Novartis AG TTM operating profit year-on-year change?
What is Novartis AG annual operating income?
The current annual operating profit of NVS is $14.54B
What is the all time high annual operating profit for Novartis AG?
Novartis AG all-time high annual operating income is $14.54B
What is Novartis AG annual operating profit year-on-year change?
Over the past year, NVS annual operating income has changed by +$4.78B (+48.88%)
What is Novartis AG quarterly operating income?
The current quarterly operating profit of NVS is $3.53B
What is the all time high quarterly operating profit for Novartis AG?
Novartis AG all-time high quarterly operating income is $5.70B
What is Novartis AG quarterly operating profit year-on-year change?
Over the past year, NVS quarterly operating income has changed by -$484.00M (-12.06%)
What is Novartis AG TTM operating income?
The current TTM operating profit of NVS is $14.54B
What is the all time high TTM operating profit for Novartis AG?
Novartis AG all-time high TTM operating income is $14.54B
What is Novartis AG TTM operating profit year-on-year change?
Over the past year, NVS TTM operating income has changed by +$2.81B (+23.98%)